Grant

Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

CountryEuropean Union (all member states)
Deadline2027-09-16 (298 days left)
Published2027-02-10
SectorsHealth & life sciences, Research & innovation, SME & startup support
SourceEU Funding & Tenders portal

Summary

Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: Patients with rare or very rare cancers or canc…

The buyer, the value, the full description and the link to the official notice are available with a free account.